The Emergency nurse Protocols Initiating Care-Sydney Triage to Admission Risk Tool (EPIC-START) trial: protocol for a stepped wedge implementation trial

• Published in: Implementation science communications 2023-06, Vol.4 (1), p.70-70, Article 70
• Main Authors: Curtis, Kate, Dinh, Michael M, Shetty, Amith, Kourouche, Sarah, Fry, Margaret, Considine, Julie, Li, Ling, Lung, Thomas, Shaw, Timothy, Lam, Mary K, Murphy, Margaret, Alkhouri, Hatem, Aggar, Christina, Russell, Saartje Berendsen, Seimon, Radhika V, Hughes, James A, Varndell, Wayne, Shaban, Ramon Z
• Format: Article
• Language: English
• Subjects: Clinical deterioration; Data collection; Emergency medical care; Emergency medical services; Health care access; Health services; Intervention; Medical records; Nurses; Overcrowding; Patients; Pediatrics; Research ethics; Study Protocol; Sustainability
• ISSN: 2662-2211; 2662-2211
• DOI: 10.1186/s43058-023-00452-0

Emergency department (ED) overcrowding is a global problem and a threat to the quality and safety of emergency care. Providing timely and safe emergency care therein is challenging. To address this in New South Wales (NSW), Australia, the Emergency nurse Protocol Initiating Care-Sydney Triage to Admission Risk Tool (EPIC-START) was developed. EPIC-START is a model of care incorporating EPIC protocols, the START patient admission prediction tool, and a clinical deterioration tool to support ED flow, timely care, and patient safety. The aim of this study is to evaluate the impact of EPIC-START implementation across 30 EDs on patient, implementation, and health service outcomes. This study protocol adopts an effectiveness-implementation hybrid design (Med Care 50: 217-226, 2012) and uses a stepped-wedge cluster randomised control trial of EPIC-START, including uptake and sustainability, within 30 EDs across four NSW local health districts spanning rural, regional, and metropolitan settings. Each cluster will be randomised independently of the research team to 1 of 4 dates until all EDs have been exposed to the intervention. Quantitative and qualitative evaluations will be conducted on data from medical records and routinely collected data, and patient, nursing, and medical staff pre- and post-surveys. Ethical approval for the research was received from the Sydney Local Health District Research Ethics Committee (Reference Number 2022/ETH01940) on 14 December 2022. Australian and New Zealand Clinical trial, ACTRN12622001480774p. Registered on 27 October 2022.